TrialJournal of psychopharmacology (Oxford, England)2025

Ketamine for treatment-resistant obsessive-compulsive disorder: Double-blind active-controlled crossover study.

Ben Beaglehole et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.